Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014 - Persky, D O; Unger, J M; Spier, C M (J Clin Oncol, 2008)
, et al; Southwest Oncology Group.